PMID- 38223199 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240501 IS - 2573-9832 (Electronic) IS - 2573-9832 (Linking) VI - 6 IP - 1 DP - 2024 Jan TI - Oleic acid stimulation of amino acid uptake in primary human trophoblast cells is mediated by phosphatidic acid and mTOR signaling. PG - 1-11 LID - 10.1096/fba.2023-00113 [doi] AB - Normal fetal development is critically dependent on optimal nutrient supply by the placenta, and placental amino acid transport has been demonstrated to be positively associated with fetal growth. Mechanistic target of rapamycin (mTOR) is a positive regulator of placental amino acid transporters, such as System A. Oleic acid (OA) has been previously shown to have a stimulatory role on placental mTOR signaling and System A amino acid uptake in primary human trophoblast (PHT) cells. We investigated the mechanistic link between OA and System A activity in PHT. We found that inhibition of mTOR complex 1 or 2, using small interfering RNA to knock down raptor or rictor, prevented OA-stimulated System A amino acid transport indicating the interaction of OA with mTOR. Phosphatidic acid (PA) is a key intermediary for phospholipid biosynthesis and a known regulator of the mTOR pathway; however, phospholipid biosynthetic pathways have not been extensively studied in placenta. We identified placental isoforms of acyl transferase enzymes involved in de novo phospholipid synthesis. Silencing of 1-acylglycerol-3-phosphate-O-acyltransferase-4, an enzyme in this pathway, prevented OA mediated stimulation of mTOR and System A amino acid transport. These data indicate that OA stimulates mTOR and amino acid transport in PHT cells mediated through de novo synthesis of PA. We speculate that fatty acids in the maternal circulation, such as OA, regulate placental functions critical for fetal growth by interaction with mTOR and that late pregnancy hyperlipidemia may be critical for increasing nutrient transfer to the fetus. CI - (c) 2023 The Authors. FASEB BioAdvances published by the Federation of American Societies for Experimental Biology. FAU - Silva, Elena AU - Silva E AUID- ORCID: 0000-0002-1579-7484 AD - Department of Obstetrics & Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado USA. FAU - Ferchaud-Roucher, Veronique AU - Ferchaud-Roucher V AUID- ORCID: 0000-0001-6809-1488 AD - University of Nantes-INRAE UMR 1280 PhAN, CHU Nantes France. FAU - Kramer, Anita AU - Kramer A AD - Department of Obstetrics & Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado USA. FAU - Madi, Lana AU - Madi L AD - Department of Obstetrics & Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado USA. FAU - Pantham, Priyadarshini AU - Pantham P AD - Ob/Gyn & Reproductive Sciences University of California, San Diego La Jolla California USA. FAU - Chassen, Stephanie AU - Chassen S AUID- ORCID: 0000-0001-6004-6463 AD - Department of Pediatrics, Section of Neonatology University of Colorado, Anschutz Medical Campus Aurora Colorado USA. FAU - Jansson, Thomas AU - Jansson T AUID- ORCID: 0000-0002-8123-9480 AD - Department of Obstetrics & Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado USA. FAU - Powell, Theresa L AU - Powell TL AUID- ORCID: 0000-0001-7410-1080 AD - Department of Obstetrics & Gynecology University of Colorado Anschutz Medical Campus Aurora Colorado USA. AD - Department of Pediatrics, Section of Neonatology University of Colorado, Anschutz Medical Campus Aurora Colorado USA. LA - eng GR - R01 HD104644/HD/NICHD NIH HHS/United States GR - UL1 TR001082/TR/NCATS NIH HHS/United States GR - UM1 TR004399/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20231114 PL - United States TA - FASEB Bioadv JT - FASEB bioAdvances JID - 101733210 PMC - PMC10782470 OTO - NOTNLM OT - Kennedy pathway OT - fatty acids OT - human OT - maternal-fetal exchange OT - mechanistic target of rapamycin OT - phosphatidic acid OT - placenta OT - pregnancy EDAT- 2024/01/15 06:43 MHDA- 2024/01/15 06:44 PMCR- 2023/11/14 CRDT- 2024/01/15 04:43 PHST- 2023/10/09 00:00 [received] PHST- 2023/10/19 00:00 [revised] PHST- 2023/10/30 00:00 [accepted] PHST- 2024/01/15 06:44 [medline] PHST- 2024/01/15 06:43 [pubmed] PHST- 2024/01/15 04:43 [entrez] PHST- 2023/11/14 00:00 [pmc-release] AID - FBA21419 [pii] AID - 10.1096/fba.2023-00113 [doi] PST - epublish SO - FASEB Bioadv. 2023 Nov 14;6(1):1-11. doi: 10.1096/fba.2023-00113. eCollection 2024 Jan.